Maurizio Bonati
Maurizio Bonati
To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study [0.03%]
基于基因多态性为中国汉族人建立预测华法林初始及维持剂量模型的多中心研究
Xiaotong Xia,Nianxu Huang,Boxia Li et al.
Xiaotong Xia et al.
Purpose: The purpose of this paper is to study the correlation between demographic and clinical factors and warfarin dose of patients in Chinese Han population taking warfarin and study gene polymorphisms impact of relate...
Jun Miura,Celestino Obua,Catherine Abbo et al.
Jun Miura et al.
Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity [0.03%]
通过以患者为中心的处方模型改善多病共存患者的药物依从性和有效处方
J González-Bueno,D Sevilla-Sánchez,E Puigoriol-Juvanteny et al.
J González-Bueno et al.
Purpose: This study aimed to assess the impact of the patient-centered prescription (PCP) model in medication adherence and effective prescribing in patients with multimorbidity. ...
Correction to: Evaluation of drug‑drug interactions of pemigatinib in healthy participants [0.03%]
Correction to: 评估pemigatinib健康参与者中药药相互作用
Tao Ji,Kevin Rockich,Noam Epstein et al.
Tao Ji et al.
Response/comments to maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery-Karel Allegaert, Michael Ceulemans, John van den Anke [0.03%]
关于母亲使用对乙酰氨基酚和胎儿动脉导管闭合的反应/评论：增加风景中的碎片-Karel Allegaert，Michael Ceulemans，John van den Anker
Manfred Hauben,Stephen Bai,Eric Hung et al.
Manfred Hauben et al.
Correction to: Calling for an exponential escalation scheme in vaccine development for COVID-19 [0.03%]
Correction to: 关于呼吁建立指数型提升方案以开展COVID-19疫苗研发的评论文章
Martin Wehling
Martin Wehling
Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence [0.03%]
阿托伐他汀和罗舒伐他汀高剂量强化治疗急性冠脉综合征患者经皮冠状动脉介入治疗的疗效：随机对照试验GRADE证据分级meta分析研究
Josip A Borovac,Mette Leth-Olsen,Marko Kumric et al.
Josip A Borovac et al.
Purpose: We aimed to summarize current evidence regarding the impact of a high-dose statin loading before percutaneous coronary intervention (PCI) on short-term outcomes in patients presenting with the acute coronary synd...
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment [0.03%]
生理药动学模型预测CYP3A抑制剂/诱导剂对健康受试者和肝功能不全患者中esaxerenone药动学影响的临床研究
Akiko Watanabe,Tomoko Ishizuka,Makiko Yamada et al.
Akiko Watanabe et al.
Purpose: Esaxerenone is a novel, oral, nonsteroidal treatment for hypertension. Physiologically based pharmacokinetic (PBPK) modelling was performed to predict the drug-drug interaction (DDI) effect of cytochrome P450 (CY...
Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy [0.03%]
血液透析依赖性慢性肾病患者接受长期肾脏替代治疗过程中的 Fondaparinux 药物代谢动力学-药物效应动力学研究
Danica Michaličková,Jan Miroslav Hartinger,Zuzana Hladinová et al.
Danica Michaličková et al.
Purpose: Data on the anti-Xa efficacy of fondaparinux in dialysis-dependent chronic kidney disease (DD-CKD) patients are scarce. This study characterizes the pharmacokinetics (PK) and pharmacodynamics (PD) of fondaparinux...
Observational Study
European journal of clinical pharmacology. 2022 Jan;78(1):89-98. DOI:10.1007/s00228-021-03201-1 2022